UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|
|
|
(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation) | File Number) | Identification No.) |
(Address of principal executive offices) (ZIP Code)
Registrant’s telephone number, including area code: (
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbols | Name of each exchange on which registered | ||
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On May 11, 2023, Dynatronics Corporation ("Company") issued a press release reporting, among other things, financial results relating to the quarter ended March 31, 2023. Also, as previously announced by a press release issued on April 27, 2023, on May 11, 2023, the Company held a conference call in which executives of the Company reviewed the fiscal 2023 third quarter results. The live webcast and slide presentation can be accessed via the Company's Investor Relations website under the Events & Presentations tab at https://investors.dynatronics.com/services. The full text of the press release is furnished herewith as Exhibit 99.1. The slide presentation that accompanied the earnings conference call is furnished as Exhibit 99.2.
The information under this Item 2.02 and in Exhibits 99.1 and 99.2, is being "furnished" and is not being "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference into any filing of the registrant under the Securities Act of 1933, whether made before or after the date hereof, regardless of any general incorporation language in any such filing, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
Exhibit Number |
Description | |
99.1 | Press Release dated May 11, 2023 | |
99.2 | Slide Presentation accompanying earnings conference call held May 11, 2023 | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 11, 2023 | DYNATRONICS CORPORATION | ||
By: | /s/John A. Krier | ||
Name: | John A. Krier | ||
Title: | President, Chief Executive Officer, and Chief Financial Officer |
Dynatronics Corporation Reports Third Quarter Fiscal Year 2023 Financial Results and Business Highlights
EAGAN, MN / ACCESSWIRE / May 11, 2023 / Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its third quarter of fiscal year 2023 ended March 31, 2023, and provided an update on the business.
CEO Commentary
"Dynatronics experienced revenue challenges in our third fiscal quarter as a result of three external factors. As a result, we are adjusting our spending and revenue expectations as we respond to the specific impacts of:
We are being more conservative in our baseline case and have focused our actions on what we can control," said John Krier, Chief Executive Officer of Dynatronics.
"Despite the revenue headwinds caused by these external factors, gross margin continued to improve year-over-year at 23.9% versus 22.4% in the prior year. Our inventory balance was reduced to $9.7 million with a reduction of approximately $2.4 million from the balance on June 30, 2022. Q3 represented our 11th consecutive quarter of operating with no debt, but we are mindful of the need to retain flexibility through additional working capital reductions, strategic evaluation of an asset-based line of credit, and possible use of our ATM facility, as appropriate" concluded Krier.
Key Financial Highlights
Q3 Fiscal Year '23 Financial Highlights
Note: All financials referenced in this release are in conformity with U.S. Generally Accepted Accounting Principles ("GAAP") and comparisons in this release are to the same period in the prior year unless otherwise noted.
Guidance for Fiscal Year '23
Dynatronics reassessed net sales guidance for fiscal year '23 based on the impact of the previously mentioned external events to $39.5 million to $40.5 million. Q4 of fiscal year '23 is expected to be $7.5 million to $8.5 million. The Company has reset its quarterly net sales baseline for fiscal year '24 to $9.25 million and expects the distribution of net sales across future quarters to align with historical trends, which are highest in the first quarter, lower in the second and third quarters, with a bounce back in the fourth quarter.
Given the external events that have caused a reduction in revenue and the continued macro-economic challenges, the Company is deferring providing gross margin guidance.
Selling, general, and administrative expenses are anticipated to be 35% to 40% of net sales in Q4 of fiscal year '23. The Company highlighted approximately $1.5 million to $2.0 million in expected cost reductions in selling, general, and administrative expenses in fiscal year 2024, from the run-rate as of March 2023.
Dynatronics expects to continue to strategically optimize its working capital position while aiming to improve supplier relationships. This approach allowed the company to generate positive cash flow from operations of $0.4 million for the first nine months of the fiscal year while reducing current liabilities by $1.3 million over the same period.
The Company's financial guidance for fiscal year '23 is subject to the risks identified in its safe harbor notification below. The Company continues to expect volatility due to the challenges related to the broader economic environment and the COVID-19 global pandemic, including higher raw material, delivery and shipment costs, supply chain disruptions, extended handling times and delays or disruption in procedure volume. Dynatronics also expects some ongoing volatility from the Company's business optimization.
Conference Call and Webcast Q3 Fiscal Year '23 Results
The Company will hold a conference call and live audio webcast to discuss the results, consisting of prepared remarks by management, slide presentation, and a question-and-answer session with analysts, beginning at 8:00 AM ET on Thursday, May 11, 2023.
Interested persons may access the live conference call by dialing 800-319-4610 (U.S./Canada callers) or 604-638-5340 (international callers). To join the call, it is recommended that participants call or log in 10 minutes ahead of the scheduled start time to ensure proper connection, and simply ask to join the Dynatronics call. No passcode is required.
The live webcast and slide presentation can be accessed on the Company's Investor webpage under the Events & Presentations tab at https://www.dynatronics.com/investors/. The webcast will be archived on the website for future viewing.
About Dynatronics Corporation
Dynatronics is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The Company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The Company's products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin®, Solaris™, Hausmann®, Physician's Choice®, and PROTEAM™, among others. More information is available at www.dynatronics.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Those statements include references to the Company's expectations and similar statements. Such forward-looking statements reflect the views of management at the time such statements are made. These statements include our statements regarding the Company's expected overall performance, expectations regarding the Company's long-term gross margins, operating income and cash flow from operations, expectations regarding net sales, gross margin, selling general and administrative costs, and other income in fiscal year 2023, expectations regarding the timing and scope of new product releases, and uncertainties related to the broader economic environment, the impact of the COVID-19 global pandemic on the Company's gross margin, and volatility resulting from continued execution of the Company's business optimization strategy. These forward-looking statements are subject to a number of risks, uncertainties, estimates, and assumptions that may cause actual results to differ materially from current expectations. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in the Company's annual, quarterly, and other reports filed with the Securities and Exchange Commission. Dynatronics does not undertake to update its forward-looking statements, whether as a result of new information, future events, or otherwise.
About Non-GAAP Financial Measures
Continued product net sales as used in this press release is a non-GAAP measure as defined under the rules of the Securities and Exchange Commission. The Company defines continued product net sales as sales excluding discontinued products and sales of physical therapy and rehabilitation products through our direct sales channel. Management uses this non-GAAP measure to evaluate our operating performance and to forecast future periods. Management believes this non-GAAP measure provides investors with additional information about the Company's ongoing operating performance and is not intended as a substitute for, or superior to, the financial measure prepared in accordance with GAAP. Investors are cautioned against placing undue reliance on this non-GAAP measure. $37 million annual and $9.25 million quarterly baseline continued product net sales set in April 2021 is based on annual net sales of approximately $48 million in FY '21 less estimated annual discontinued product sales of approximately $11 million.
Summary Financial Results
Following is a summary of operating results for the periods ended March 31, 2023, the balance sheet highlights at March 31, 2023 and cash flow for periods ended March 31, 2023.
Summary Selected Financial Data
Statements of Operation Highlights
In thousands, except share and per share amounts
Quarter Ended | ||||||
March 31 | ||||||
2023 | 2022 | |||||
Net sales | $ | 9,235 | $ | 10,316 | ||
Cost of sales | 7,028 | 8,005 | ||||
Gross Profit | 2,207 | 2,311 | ||||
23.9% | 22.4% | |||||
Selling, general and administrative expenses | 3,429 | 3,747 | ||||
Other (expense) income, net | (25 | ) | (36 | ) | ||
Net income (loss) | $ | (1,247 | ) | $ | (1,472 | ) |
Preferred stock dividend, in common stock, issued or to be issued | (175 | ) | (182 | ) | ||
Net income (loss) attributable to common stockholders | $ | (1,422 | ) | $ | (1,654 | ) |
Net loss attributable to common stockholders per | ||||||
common share - basic and diluted | $ | (0.36 | ) | $ | (0.46 | ) |
Weighted-average common shares outstanding - basic and | ||||||
diluted | 3,929,577 | 3,587,857 |
Balance Sheet Highlights
In thousands
March 31, 2023 | June 30, 2022 | |||||
Cash and cash equivalents and restricted cash | $ | 670 | $ | 701 | ||
Trade accounts receivable, net | 4,367 | 5,416 | ||||
Inventories, net | 9,703 | 12,071 | ||||
Prepaids & other | 993 | 1,038 | ||||
Total current assets | 15,733 | 19,226 | ||||
Non-current assets | 17,706 | 16,208 | ||||
Total assets | $ | 33,439 | $ | 35,434 | ||
Accounts payable | $ | 6,167 | $ | 6,169 | ||
Accrued payroll and benefits expense | 812 | 1,360 | ||||
Accrued expenses | 16 | 862 | ||||
Other current liabilities | 1,594 | 1,544 | ||||
Line of credit | - | - | ||||
Total current liabilities | 8,589 | 9,935 | ||||
Non-current liabilities | 5,635 | 3,800 | ||||
Total liabilities | 14,224 | 13,735 | ||||
Stockholders' equity | 19,215 | 21,699 | ||||
Total liabilities and stockholders' equity | $ | 33,439 | $ | 35,434 |
Cash Flow Highlights
In thousands
Nine Months Ended | ||||||
March 31 | ||||||
2023 | 2022 | |||||
Net loss | $ | (2,592 | ) | $ | (2,427 | ) |
Depreciation and amortization | 1,008 | 1,085 | ||||
Stock-based compensation | 109 | 149 | ||||
(Gain) loss on sale of property and equipment | - | - | ||||
Receivables | 1,050 | 516 | ||||
Inventory | 2,368 | (5,105 | ) | |||
Prepaid and other assets | 67 | 951 | ||||
Accounts payable, accrued expenses, and other liabilities | (1,605 | ) | 1,571 | |||
Net cash provided by (used in) operating activities | 405 | (3,260 | ) | |||
Net cash used in investing activities | (177 | ) | (261 | ) | ||
Payments on non-current liabilities | (259 | ) | (261 | ) | ||
Proceeds from issuance of common stock, net | - | - | ||||
Net cash used in financing activities | (259 | ) | (261 | ) | ||
Net change in cash and cash equivalents | (31 | ) | (3,782 | ) | ||
Cash and cash equivalents at beginning of the period | 701 | 6,253 | ||||
Cash and cash equivalents at end of the period | $ | 670 | $ | 2,471 |
Contact:
Dynatronics Corporation
Investor Relations
ir@dynatronics.com
For additional information, please visit: www.dynatronics.com
Connect with Dynatronics on LinkedIn
SOURCE: Dynatronics Corporation
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end
?ZW/\
M1R/4&EC<)4KU&XQ33C;==))_BKH>#Q,*,$I2::E?_P E:_!V.K_9_P#%.L^*
M?!'QGL=8U6\U6TD\-2WC17L[2CSE88D^8G#<]?IZ5V_BZ+P?H?P(^%.DZEXS
MUSPCI]WIK:@T>BV'G)>7#,-[R.'7+*3@ YQFOFCP)\3-4^'MCXEM-.@M)H]?
MTY],NC=(S%(F()*;6&&XZG(]JZ3P7\?]2\-^$8O"NL:!HGC+P[;RF:UL] (/V8- UN?4[NWUW7M(U.]\4
M1>+DO[*6W,EM>QP+ !&)(67RS&N"KJQRQY'&.9M?B%X_\&?$SP%X+U_Q/H'B
M<:GKM]97-[I]N(KEK9+ W$*W$0)6&8./X#ADVG R17&ZE\AW&H^/M;\-_VE/I@N_L]G:6OG(1'O4-)D$9)QSR.,4 =M9_LA>'IK>WT
MV'QYXIE\,Z9XA'B"ST*">R%O:WRW/VA@SBW\V1?,+?)([8#'N%(T]#_94\'K
M>0W+:WK&N:/#JFJZE;:5WME#K5[Y%E+<,
MT$(5)D4)&3M7"C' KS#5OVG/%NN>-_"'BJ]MM*EU3PPA2T"V[I%(-Q8"15<=
M-V $V@ "N7\)?%;5O!GQ/3QW96]E+JZW4UV(;A',&^3=N&T,&Q\YQ\WIUK&.
M7U73GSQ7,X-+79N4GO;LUJ:RQU)3CR-\JFF_11BN_=/0]P_9Y^(OB3Q-^U9)
M'J6LWMY;:E+?07-K+.S0O&(Y"J;"<;1@8&.,5I_"B#P_X=_9I\8ZA=Z]J/A4
MW_B/^S[S4]'M//N%A504A.&4JC$G)SWQWKYY\!?%#5?AU\08?&&FV]G/J<3S
M2+%=([0YD5E;(5E/1CCYO2M+X=?&W6_AT^L00VFG:SHNLG.H:+JT!FM)SG(.
MW((89X(/YXK7$8"I)MTDDK0T5E?E;NMFNJLVFM#.AC81251W=YZN[MS)6>]^
MCO9IZGK^N^+/"2?L]Z_HVD^(?%'C%[._M[S3=0U#2'CBTR<,,KYV]@FY<\$C
MGIUKKG\(V'Q9^)7PZ^+-RJ#0I](;5-?;'RI6)M5TB^TQ921&;RV>(.1UQN S7NWP>^)OBW5_
M!7Q+N;[Q'J=W/9:0)K:2:Z=FA?)^923P?<5XEXC\<^(?%Z0)KFM7VK+ 28A>
M3M($)ZXR>.@K>A6Q-2M.G-1M%J]N;JKZ7_4QK43I1G!RO*]K\O1VUL8=%%
M%>H><%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %?J/_P2W_Y-_P#$'_8SW'_I):5^7%?J/_P2
MW_Y-_P#$'_8SW'_I):5\OQ)_R+W_ (H_FSZ/A_\ WY>DOR1^7%%%%?4'S@44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% 'T7K7BP^"#\#=7)_<0Z9MG'9HF<*X/\
MP$FI?B#IMG\.O$_@OP3ILR2QS:Z-:N&C/59)PL"GZ1C]:^;Z*\59:DXOFVYK
MZ;W
T10A7))R3B1<@@8)Q7HS?\ !2'XN/-$Q_L"-5<,RIIWWQZ'+G],5+_P4 ^.
M7ASXR^*_!P\,ZHFJ6.GZ8TDSQ A(YIF!* F13&1+=>K'<0,LS:%W $KG(KNM=_9Y\&
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M(ZEJ=U$SW-R;=[?:R)$L<<01SB.)8P" >>
SF07,.Q5VD-M*AQA6Y7'M@US\/[..BMH/C[3M0U[7-5F\;Z=#IVKZA
G/=17,SZ*\"O/Y9W+'()H
MI4>,M@E2N#M&>,@_+NK7OQ)\#>-OVA_%'A[QAIUJ_AC3-)U&[CNM&68ZM-%I
MN\JW[P"&-@I'R?-ELYP,&_XQ_:C^)>O^*/& \'V.H6MMX7M+-X;&R\,MJ<&H
M7,MHERZW-QYBF"/$BHNP9'+$D<4 ?0%I\ F?X>>*O!VM_$'Q?XHTWQ!9&P:;
M4WL4FLHBC(PMS!:Q*N0W.]7^Z,8YSM>*O@UH?B_3?!FFWDU[%I?A:_MM1M;*
M!T6*XDMT*PK,"A+(I(+)-3T:&XM-,DLC8R6E]+-
M!&K1*CL9K1//RY8AQM7YOFX />/$OPITGQ-\1O"?C>2YO;+7/#B7,$#6CHL=
MS!.H$D,X9"63*JX *D,H.>U_90^&OAG4M$OK72M2N+C0BXTC[?KU_=)IR-&T;10)).RQQE'(V 8^[Q\JXZ
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MPUJVJ/X>L=,-LMI-9VAGC*3>8SMOV$.&&!N^7&*WOAW\??BJ=2M?[